Operose Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-9,348
Closed -$96.8K – 628
2024
Q2
$96.8K Buy
9,348
+76
+0.8% +$833 0.03% 188
2024
Q1
$111K Buy
9,272
+64
+0.7% +$711 0.04% 189
2023
Q4
$99.4K Buy
+9,208
New +$112K 0.04% 158

Other funds holding PTEN

Operose Advisors's PTEN Position: Q3 2024 in Review

Operose Advisors sold out of Patterson-UTI (PTEN) in Q3 2024, closing a stake of 9,348 shares — an estimated $96.8K sold.

Operose Advisors first reported a position in PTEN in Q4 2023 and held it in 3 quarters. The position peaked at $111K in Q1 2024. 366 funds tracked by Wall St. Rank hold PTEN as of Q3 2024.

  • Operose Advisors reported no remaining Patterson-UTI position as of Q3 2024 after selling out during the quarter.
  • Operose Advisors sold 9,348 Patterson-UTI shares in Q3 2024, an estimated $96.8K.
  • Operose Advisors first reported a position in Patterson-UTI in Q4 2023 and held it in 3 quarters.
  • Operose Advisors's Patterson-UTI position peaked at $111K in Q1 2024.
  • 366 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2024.

Based on Operose Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.